|
Volumn 350, Issue 8, 2004, Pages 836-838
|
Hemofiltration and the Prevention of Radiocontrast-Agent-Induced Nephropathy [1] (multiple letters)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTICOAGULANT AGENT;
CONTRAST MEDIUM;
CREATININE;
HEPARIN;
OXYGEN RADICAL;
RADIOPHARMACEUTICAL AGENT;
ANTICOAGULANT THERAPY;
COST EFFECTIVENESS ANALYSIS;
CREATININE CLEARANCE;
DISEASE SEVERITY;
HEMODIALYSIS;
HEMOFILTRATION;
HIGH RISK PATIENT;
HUMAN;
INTENSIVE CARE UNIT;
KIDNEY DISEASE;
KIDNEY DYSFUNCTION;
KIDNEY FAILURE;
KIDNEY INJURY;
KIDNEY ISCHEMIA;
LETTER;
MORBIDITY;
MORTALITY;
OUTCOMES RESEARCH;
OXIDATIVE STRESS;
PATIENT SELECTION;
PRIORITY JOURNAL;
REPERFUSION INJURY;
TECHNIQUE;
TREATMENT INDICATION;
BLOOD;
NOTE;
ACUTE KIDNEY FAILURE;
ANGIOCARDIOGRAPHY;
CARDIOVASCULAR DISEASE;
INTENSIVE CARE;
METHODOLOGY;
CONTRAST MEDIA;
CREATININE;
HEMOFILTRATION;
HUMANS;
KIDNEY DISEASES;
RADIOPHARMACEUTICALS;
ANTICOAGULANTS;
CARDIOVASCULAR DISEASES;
CORONARY ANGIOGRAPHY;
HOSPITAL MORTALITY;
INTENSIVE CARE;
KIDNEY FAILURE, ACUTE;
RESEARCH DESIGN;
|
EID: 12144290806
PISSN: 00284793
EISSN: None
Source Type: Journal
DOI: 10.1056/NEJM200402193500816 Document Type: Letter |
Times cited : (5)
|
References (0)
|